Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. [clinicaltrials:NCT00259571]
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. [clinicaltrials:NCT00259571]
Bio2RDF identifier
NCT00259571
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00259571
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... inflamed parts of the colon.
brief title [clinicaltrials_vocabulary:brief-title]
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2010-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-11-28T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
non-inferiority study
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-12-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00259571
official title [clinicaltrials_vocabulary:official-title]
Prospektive, Randomisierte, Do ...... rhaltung Der Colitis Ulcerosa.
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
EC - L389/2003
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2005-11-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Missing financial sponsorship
identifier
clinicaltrials:NCT00259571
title
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
@en
type
label
Retarded Phosphatidylcholine V ...... . [clinicaltrials:NCT00259571]
@en